Literature DB >> 21209048

What do we tell our patients about calcium and vitamin D supplementation?

Sundeep Khosla.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21209048     DOI： 10.1210/jc.2010-2760

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  2 in total

1.  Activation of FGF-23 mediated vitamin D degradative pathways by cholecalciferol.

Authors:  Hala Alshayeb; Arif Showkat; Barry M Wall; Geeta G Gyamlani; Valentin David; L Darryl Quarles
Journal:  J Clin Endocrinol Metab       Date:  2014-06-24       Impact factor: 5.958

2.  Prevalence and Factors Associated with Vitamin D Deficiency and Hyperparathyroidism in HIV-Infected Patients Treated in Barcelona.

Authors:  Elisabet Lerma; M Ema Molas; M Milagro Montero; Ana Guelar; Alicia González; Judith Villar; Adolf Diez; Hernando Knobel
Journal:  ISRN AIDS       Date:  2012-07-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.